Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis (Q32054951)

6 July 2017

Irbesartan, an angiotensin type 1 receptor inhibitor, regulates markers of inflammation in patients with premature atherosclerosis (English)

1 reference

6 July 2017

0 references

1 reference

S Navalkar

1

1 reference

6 July 2017

S Parthasarathy

series ordinal

2

1 reference

6 July 2017

N Santanam

series ordinal

3

1 reference

6 July 2017

B V Khan

series ordinal

4

1 reference

6 July 2017

language of work or name

English

0 references

publication date

1 February 2001

1 reference

Journal of the American College of Cardiology

6 July 2017

1 reference

6 July 2017

37

1 reference

6 July 2017

2

1 reference

6 July 2017

440-444

1 reference

The pathogenesis of atherosclerosis: a perspective for the 1990s

6 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

The angiotensin-II receptor antagonist, losartan, inhibits LDL lipid peroxidation and atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

A 5-year comparison of doxazosin and atenolol in patients with mild-to-moderate hypertension: effects on blood pressure, serum lipids, and coronary heart disease risk.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Review of preclinical data of calcium channel blockers and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Pharmacology of carvedilol: rationale for use in hypertension, coronary artery disease, and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Angiotensin II and the adrenal

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Role of AT1 receptors in the central control of sympathetic vasomotor function.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Identification of angiotensin II receptor subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Clinical experience with the angiotensin II receptor antagonist losartan. A preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Nitric oxide and the depressor response to angiotensin blockade in hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Evaluation of serum levels of solubilized adhesion molecules and cytokine receptors in coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Circulating adhesion molecules and severity of coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

UltraRapid communications : vascular superoxide production by NAD(P)H OxidaseAssociation with endothelial dysfunction and clinical risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Increased NADH-Oxidase–Mediated Superoxide Production in the Early Stages of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Superoxide: a two-edged sword

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Angiotensin II-induced superoxide anion generation in human vascular endothelial cells: role of membrane-bound NADH-/NADPH-oxidases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Evidence for a causal role of the renin-angiotensin system in nitrate tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Increased levels of soluble tumor necrosis factor receptors in atherosclerosis: no clear relationship with levels of tumor necrosis factor.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

Plasma soluble adhesion molecules and endothelium-dependent vasodilation in early human atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901138-4

7 January 2021

10.1016/S0735-1097(00)01138-4

Identifiers

DOI

1 reference

6 July 2017

1 reference